Health
Weight-based dosing strategy may affect immunotherapy outcomes, shows study – News-Medical.Net
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when…
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
The findings, published in…
Continue Reading
-
Business12 hours agoRanking the best “Magnificent Seven” stocks to buy for 2026. Here’s my No. 5 pick.
-
General9 hours agoFormer truck driver’s garage memorabilia collection sold to Westonia to drive tourism
-
Noosa News15 hours agoInside the big change in homebuyer habits during the Christmas holidays
-
Noosa News9 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified